Ziemons, Janine http://orcid.org/0000-0002-4559-5488
Hillege, Lars E. http://orcid.org/0000-0001-7010-7610
Aarnoutse, Romy http://orcid.org/0000-0002-8713-9747
de Vos-Geelen, Judith http://orcid.org/0000-0003-2578-1766
Valkenburg-van Iersel, Liselot http://orcid.org/0000-0003-2925-9908
Mastenbroek, Jasper
van Geel, Robin http://orcid.org/0000-0003-1880-8131
Barnett, David J. M. http://orcid.org/0000-0003-1961-7206
Rensen, Sander S. http://orcid.org/0000-0001-5054-8400
van Helvoort, Ardy http://orcid.org/0000-0002-3585-0676
Dopheide, Lotte H. J. http://orcid.org/0009-0001-5878-0877
Roeselers, Guus http://orcid.org/0000-0002-4725-6105
Penders, John http://orcid.org/0000-0001-9146-5919
Smidt, Marjolein L. http://orcid.org/0000-0002-8328-1869
Venema, Koen http://orcid.org/0000-0001-7046-5127
Funding for this research was provided by:
TKI Agri & Food (LWV20.345)
Danone Nutricia Research (LWV20.345)
Article History
Received: 30 January 2024
Accepted: 18 June 2024
First Online: 26 June 2024
Declarations
:
: Participants had previously participated in another study (ICTR platform NTR7478) and gave consent for being contacted again for follow-up research. The current study was approved by the Medical Ethics Committee of the Academisch Ziekenhuis Maastricht/Universiteit Maastricht (METC azM/UM) and written informed consent was received from each participant. The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice.
: Not applicable.
: JZ and MLS have received research funding from Danone Nutricia Research. GR, LHJD, and AvH are employed by Danone Nutricia Research. RA, JdVG, and MLS have received institutional research funding from Servier, outside the submitted work. JdVG has served as a consultant for Amgen, AstraZeneca, MSD, Pierre Fabre, and Servier, all outside the submitted work. KV acknowledges support in funding from the Dutch Province of Limburg. All other authors have no competing interests.